Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

Heart bypass surgery is a new beginning for patients, significantly enhancing longevity and quality of life. It is performed when critical blockages a ...

Stent selection and concomitant antithrombotic strategies are the key considerations when finding the best balance between these opposite threats. Drug-eluting stents should be avoided or strictly ...

A LARGE multinational study has revealed that patients with diabetes mellitus (DM) face significantly worse long-term outcomes following percutaneous coronary intervention (PCI) for coronary ...

Elixir’s leading technology platform, the DynamX® bioadaptor, was designed to address the shortcomings of current PCI technologies such as drug-eluting stents and work toward a continued ...

Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual antiplatelet therapy should last after PCI. Cardiologists have to carefully ...

Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I remain neutral on TFX stock.

Terumo India introduces innovative ‘Occlusafe’ in liver cancer treatment: Shardul Nautiyal, Mumbai Saturday, March 15, 2025, 08:00 Hrs [IST] Terumo India Private Limited has t ...

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

The global neurovascular device market is poised for steady expansion, with market valuation expected to reach USD 3.0 billion in 2024, according to the latest report by Future Market Insights. The ...